New Hybrid PET/MRI System Developed for Enhanced Breast Cancer Imaging
|
By MedImaging International staff writers Posted on 02 Feb 2016 |
|
Image: The SiPM detector (Photo courtesy of Volkmar Schultz, Aachen University).
A novel imaging technique is being developed that can improve breast cancer detection and characterization, and help clinicians evaluate the response of the cancer to treatment.
The 4-year project, named Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer (HYPMED), began on January 1, 2016, and is being developed under a new cross-European project coordinated by the European Institute for Biomedical Imaging Research (EIBIR; Vienna, Austria). Other HYPMED project partners include the University Hospital Aachen (UKA; Aachen, Germany), and four other research institutes in Germany and The Netherlands. Four industry partners in Germany, France, and the Netherlands, including Royal Philips (Amsterdam, The Netherlands) are also taking part.
Breast cancer is still the most common female cancer, and a major cause of cancer death in women. The stage at which breast cancer is detected is at the moment the most important factor indicating survival of the patient, and there is a pressing need to improve early diagnosis of the disease.
The HYPMED project will develop a hybrid Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) imaging system intended to improve diagnosis of breast cancer, and provide personalized control of therapy results. The consortium intends to develop a Radio Frequency (RF) coil that can used in any standard clinical MR scanner, transforming the scanner into a high-resolution hybrid PET/MRI system that can identify extremely small breast cancer foci, better characterize the cancer, and improve treatment response. The radiation dose of the new system is expected to be minimal, comparable to a regular digital mammogram. The consortium also plans to use the HYPMED approach in the future for prostate cancer detection, hybrid cardiac imaging, and other diseases.
Scientific Coordinator of the project, Professor Christiane Kuhl, University Hospital Aachen, said, “The HYPMED project combines visionary clinical expertise with excellence in physical and engineering sciences and the developed technology will greatly help us to choose an appropriate treatment that is exactly right for a given cancer in a given woman.”
Related Links:
EIBIR
UKA
Royal Philips
The 4-year project, named Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer (HYPMED), began on January 1, 2016, and is being developed under a new cross-European project coordinated by the European Institute for Biomedical Imaging Research (EIBIR; Vienna, Austria). Other HYPMED project partners include the University Hospital Aachen (UKA; Aachen, Germany), and four other research institutes in Germany and The Netherlands. Four industry partners in Germany, France, and the Netherlands, including Royal Philips (Amsterdam, The Netherlands) are also taking part.
Breast cancer is still the most common female cancer, and a major cause of cancer death in women. The stage at which breast cancer is detected is at the moment the most important factor indicating survival of the patient, and there is a pressing need to improve early diagnosis of the disease.
The HYPMED project will develop a hybrid Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) imaging system intended to improve diagnosis of breast cancer, and provide personalized control of therapy results. The consortium intends to develop a Radio Frequency (RF) coil that can used in any standard clinical MR scanner, transforming the scanner into a high-resolution hybrid PET/MRI system that can identify extremely small breast cancer foci, better characterize the cancer, and improve treatment response. The radiation dose of the new system is expected to be minimal, comparable to a regular digital mammogram. The consortium also plans to use the HYPMED approach in the future for prostate cancer detection, hybrid cardiac imaging, and other diseases.
Scientific Coordinator of the project, Professor Christiane Kuhl, University Hospital Aachen, said, “The HYPMED project combines visionary clinical expertise with excellence in physical and engineering sciences and the developed technology will greatly help us to choose an appropriate treatment that is exactly right for a given cancer in a given woman.”
Related Links:
EIBIR
UKA
Royal Philips
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Breast Imaging Workstation
SecurView
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C
New
Ultrasound Table
Ergonomic Advantage (EA) Line
Latest Nuclear Medicine News
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
- New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease
Channels
Radiography
view channel
Novel Breast Imaging System Proves As Effective As Mammography
Breast cancer remains the most frequently diagnosed cancer among women. It is projected that one in eight women will be diagnosed with breast cancer during her lifetime, and one in 42 women who turn 50... Read more
AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
Radiologists typically detect one case of cancer for every 200 mammograms reviewed. However, these evaluations often result in false positives, leading to unnecessary patient recalls for additional testing,... Read more
MRI
view channel
World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
The world's first whole-body ultra-high field (UHF) MRI has officially come to market, marking a remarkable advancement in diagnostic radiology. United Imaging (Shanghai, China) has secured clearance from the U.... Read more
World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
MRI scanners are daily tools for doctors and healthcare professionals, providing unparalleled 3D imaging of the brain, vital organs, and soft tissues, far surpassing other imaging technologies in quality.... Read more
Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more.jpg "Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)")
Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read moreUltrasound
view channel
First AI-Powered POC Ultrasound Diagnostic Solution Helps Prioritize Cases Based On Severity
Ultrasound scans are essential for identifying and diagnosing various medical conditions, but often, patients must wait weeks or months for results due to a shortage of qualified medical professionals... Read more
Largest Model Trained On Echocardiography Images Assesses Heart Structure and Function
Foundation models represent an exciting frontier in generative artificial intelligence (AI), yet many lack the specialized medical data needed to make them applicable in healthcare settings.... Read more.jpg "Image: The Sonic Lumen Tomography (SLT) intravascular ultrasound system has received FDA 510(k) clearance (Photo courtesy of Provisio Medical)")
Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
The current standard of care of using angiographic information is often inadequate for accurately assessing vessel size in the estimated 20 million people in the U.S. who suffer from peripheral vascular disease.... Read more
General/Advanced Imaging
view channel
Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy
One of the most significant challenges in oncology care is disease complexity in terms of the variety of cancer types and the individualized presentation of each patient. This complexity necessitates a... Read more
PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
A key challenge for clinicians treating patients with multiple sclerosis (MS) is that after a certain amount of time, they continue to worsen even though their MRIs show no change. A new study has now... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Hologic, Inc. (Marlborough, MA, USA) has entered into a definitive agreement to acquire Endomagnetics Ltd. (Cambridge, UK), a privately held developer of breast cancer surgery technologies, for approximately... Read more
Bayer and Google Partner on New AI Product for Radiologists
Medical imaging data comprises around 90% of all healthcare data, and it is a highly complex and rich clinical data modality and serves as a vital tool for diagnosing patients. Each year, billions of medical... Read more
